On July 28 each year, the World Health Organization celebrates the World Viral Hepatitis Day, bringing the world together under one theme to raise awareness of the global burden of viral hepatitis and the impact on real change.
In 2020, the slogan for the celebration will be “A future free of hepatitis”, as this year’s celebration focuses on preventing hepatitis B (B) among mothers and newborns. Hepatitis B virus can be prevented in newborns through the use of safe and effective vaccines.
Hepatitis, a disease often caused by a viral infection. There are five major viruses that cause this inflammation and are referred to as patterns: (a), (b), (c), (d) and (e) # A / B / C / D / E #. These patterns are of great concern due to the burden of disease and deaths due to infection with the virus, as well as the ability of different viruses to cause outbreaks and epidemics. In particular, it is noted that patterns B, C, and C cause hundreds of millions of people to develop chronic disease and together they constitute the most common causes of cirrhosis and liver cancer. Hepatitis A and E) and (E) often occur as a result of ingestion. Contaminated food or water. Hepatitis B, C, and D B), C, and D usually occur as a result of contact with contaminated body fluids by injection. Contaminated equipment is used.
Amid the continuing Covid 19 pandemic, viral hepatitis continues to claim thousands of lives every day. Around the world, 290 million people live with viral hepatitis unaware, that is, out of every 10 people with viral hepatitis 9 of them do not know they have this virus. Without finding the undiagnosed and tied to care, millions will continue to suffer, and lives will be lost.
On World Hepatitis Day, we invite people from all over the world to take action and raise awareness to find “millions missing”, which is a great opportunity for us to raise awareness of the importance of knowing the status of hepatitis and spread the word about treatment.
Hepatitis Day is celebrated on July 28 after the adoption of a resolution during the 63rd World Health Assembly in May 2010. World Hepatitis Day has received global support as the primary focus of national and international outreach efforts, and the decision stipulates that July 28 World Hepatitis Day will be devoted to providing an opportunity to raise awareness and increase understanding of viral hepatitis as a global public health problem, and to stimulate the strengthening of preventive measures and control of this disease In member states. He was chosen on the date of 28 July to celebrate the International Day of Viral Hepatitis, in commemoration of the birth of the scientist “Baroque Samuel Bloomberg”, who won the Nobel Prize in Medicine in 1976, he is the discoverer of the hepatitis B virus, and the first innovator of the vaccine against him.
The World Health Organization has called on countries to take advantage of the recent costs of diagnosing and treating viral hepatitis and to promote wider investment in eradicating the disease. According to a new study conducted by the organization and published in the World Health Magazine, an investment of $ 6 billion annually in eliminating hepatitis in 67 low and middle income countries would prevent 4.5 million premature deaths by 2030, and more than 26 million deaths After that target date.
A total of US $ 58.7 billion is required to eliminate viral hepatitis as a public health threat in these sixty-seven countries by 2030.
This means reducing new cases of hepatitis by 90% and reducing deaths by 65%.
As stated by Dr. Tedros Adhanum Gebresos, Director-General of the World Health Organization, 80% of people living with hepatitis still lack the prevention, examination and treatment services for this disease.
Hepatitis B (B) is a viral infection that infects the liver and can cause both acute and chronic diseases. The most common methods of transmission of the virus are from mother to child during birth and delivery, as well as transmission through contact with the blood of the infected person or other body fluids.
The World Health Organization estimates in 2015 that 257 million people were living with chronic hepatitis B infection (known to have been found to have hepatitis B. Surface hepatitis B. In 2015, hepatitis B resulted in an estimated 887,000 deaths, most of which were caused For cirrhosis and hepatocellular carcinoma ie primary liver cancer.
In 2017, 1.1 million people were infected with new infections. Whereas, in 2016, it was estimated that 27 million people, or 10.5% of all people estimated to be living with hepatitis B, were aware of infection, while 4.5 million people, or 16.7% of people diagnosed, were receiving treatment. Hepatitis B is a liver infection that can be life threatening and is caused by the virus from this infection. This inflammation is a prominent global health problem. It can cause chronic infection and put people at serious risk of death from cirrhosis and liver cancer. It is possible to prevent hepatitis B by receiving a safe and effective vaccine currently available, and a safe anti-hepatitis B vaccine is available, and this vaccine is 98-100% effective in preventing infection with this infection.
Prevention of hepatitis B infection prevents complications from the disease, including chronic diseases and liver cancer.
The prevalence of hepatitis B is highest in the WHO Western Pacific Region and the WHO Africa Region, where the percentage of the adult population affected by the disease is 6.2% and 6.1%, respectively. In the WHO Eastern Mediterranean Region in the WHO Southeast Asia Region and the WHO European Region, it is estimated that infection occurred at 3.3%, 2.0% and 1.6% of the total population, respectively. In the WHO Region of the Americas, the afflicted population is 0.7%. In highly populated areas, the most common way of hepatitis B transmission is from mother to child at birth (perinatal transmission), or via horizontal transmission (exposure to contaminated blood), especially from an infected child to an unaffected child during the first five years of life . And the emergence of chronic infection is very common among infants with infection from their mothers or before the age of five.